Clinical Trial

A Study of Barzolvolimab in Patients With Atopic Dermatitis

Name: A Study of Barzolvolimab in Patients With Atopic Dermatitis — clinical trial record (NCT06727552)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

Protocol Amendment History 2 changes

notable Primary completion moved earlier: 2026-10 -> 2026-05 2026-05-06

minor Completion moved earlier: 2027-05 -> 2026-12 2026-05-06

Trial Details

NCT Number	NCT06727552
Lead Sponsor	Celldex Therapeutics
Conditions	Atopic Dermatitis
Enrollment	131 participants
Start Date	2024-12-18
Primary Completion	2026-05-06 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-11